Effects of acetylsalicylic acid on the levels of sulfane sulfur and non-protein sulfhydryl groups in mouse tissues

Pharmacological Reports

Volumn 65, Issue 1, 2013, Pages 173-178

  Bilska Wilkosz, Anna ^a   Ochenduszka, Magdalena ^a   Iciek, Małgorzata ^a   Sokołowska Jezewicz, Maria ^a   Wiliński, Bogdan ^a   Góralska, Marta ^a   Srebro, Zbigniew ^a   Włodek, Lidia ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acetylsalicylic acid (aspirin); Non protein sulfhydryl groups; Sulfane sulfur

Indexed keywords

ACETYLSALICYLIC ACID; CYSTEINE; LYSINE; SODIUM CHLORIDE; SULFUR; THIOL GROUP;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CERVICAL SPINE DISLOCATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HISTOPATHOLOGY; KIDNEY; KIDNEY HOMOGENATE; LIVER; LIVER HOMOGENATE; MOUSE; NONHUMAN; TISSUE HOMOGENATE;

EID: 84875786244     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(13)70975-7     Document Type: Article

References (38)

1. Abbott WA, Bridges RJ, Meister A: Extracellular metabolism of glutathione accounts for its disappearance from the basolateral circulation of the kidney. J Biol Chem, 1984, 259, 15393-15400.
2. Aebi S, Lauterburg BH: Divergent effects of intravenous GSH and cysteine on renal and hepatic GSH. Am J Physiol, 1992, 263, R348-R352.
3. Bilska A, Iciek M, Kwiecień I, Kaniecki K, Paliborek M, Somogyi E, Piotrowska J et al.: Effects of aspirin on the levels of hydrogen sulfide and sulfane sulfur in mouse tissues. Pharmacol Rep, 2010, 62, 304-310.
4. BostomAG, Cullelon BF: Hyperhomocysteinemia in chronic renal disease. J AmSoc Nephrol, 1999, 10, 891-900.
5. Czyż M, Watała C: Aspirin - the prodigious panacea? Molecular mechanisms of the action of acetylsalicylic acid in the organism (Polish). Post Hig Med Dosw (online), 2005, 59, 105-115.
6. Dowdy RP, Nielsen FH: Effect of histidine, histamine, and aspirin on sulfur-35 metabolism in zinc-deficient chick bone. J Nutr, 1972, 102, 529-534.
7. Harding CO, Williams P, Wagner E, Chang DS, Wild K, Colwell RE, Wolff JA: Mice with genetic γ-glutamyl transpeptidase deficiency exhibit glutathionuria, severe growth failure, reduced life spans, and infertility. J Biol Chem, 1997, 272, 12560-2567.
8. Hinchman CA, Ballatori N: Glutathione-degrading capacities of liver and kidney in different species. Biochem Pharmacol, 1990, 40, 1131-1135.
9. House JD, Brosnan ME, Brosnan JT: Characterization of homocysteine metabolism in the rat kidney. Biochem J, 1997, 328, 287-292.
10. Iciek M, Włodek L: Biosynthesis and biological properties of compounds containing highly reactive reduced sulfane sulfur. Pol J Pharmacol, 2001, 53, 215-225.
11. Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K, Kimura H: A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal, 2009, 11, 205-214.
12. Kaplowitz N, Kuhlenkamp J, Goldstein L, Reeve J: Effect of salicylates and phenobarbital on hepatic glutathione in the rat. J Pharmacol Exp Ther, 1980, 212, 240-245.
13. Kimura H: Hydrogen sulfide: its production, release and functions. Amino Acids, 2011, 41, 13-121.
14. Kimura H: Metabolic turnover of hydrogen sulfide. Front Physiol, 2012, 3, 101-103.
15. Lauterburg BH, Adams JD, Mitchell JR: Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology, 1984, 4, 586-590.
16. Lowry O, Rosebrough NJ, Farr AL, Randal RJ: Protein measurement with the Folin fenol reagent. J Biol Chem, 1951, 193, 265-275.
17. Mehta RG, Steele V, Kelloff GJ, Moon RC: Influence of thiols and inhibitors of prostaglandin biosynthesis on the carcinogen-induced development of mammary lesions in vitro. Anticancer Res, 1991, 11, 587-591.
18. Meister A, Anderson ME: Glutathione. Ann Rev Biochem, 1983, 2, 711-760.
19. Meister A, Tate SS: Glutathione and related γ-glutamyl compounds. Biosynthesis and utilization. Ann Rev Biochem, 1976, 45, 559-604.
20. Morgan G: Aspirin and colorectal cancer? Eur J Public Health, 2004, 14, 105-106.
21. Morgan G: Could vitamin S (salicylate) protect against childhood cancer? Med Hypotheses, 2005, 64, 661-664.
22. Ogasawara Y, Isoda S, Tanabe S: Tissue and subcellular distribution of bound and acid-labile sulfur and the enzymatic capacity for sulfide production in rat. Biol Pharm Bull, 1994, 418, 379-404.
23. Sedlak J, Lindsay RH: Estimation of protein and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem, 1969, 25, 192-205.
24. Setia S, Sanyal SN: Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis. Pharmacol Rep, 2012, 64, 615-624.
25. Srebro Z, Iciek M, Sura P, Góralska M: The glial Gomori-positive material is sulfane sulfur. Folia Histochem Cytobiol, 2008, 46, 1-5.
26. Srebro Z, Somogyi E, Wiliński B, Góralska M, Wiliński J, Sura P: Aspirin augments the concentration of endogenous hydrogen sulfide in mouse brain and liver. Folia Med Cracov, 2006, 47, 87-91.
27. Srebro Z, OElebodziński A: Periventricular Gomoripositive glia in the hypothalamus of the rabbit. Folia Biol (Kraków), 1966, 14, 391-395.
28. Stipanuk MH, de la Rosa J, Hirschberger LL: Catabolism of cyst(e)ine by rat renal cortical tubules. J Nutr, 1990, 120, 450-458.
29. Sura P, Srebro Z, Wiliński B, Góralska M: The effect of aspirin on Gomori-positive glia in mouse brain. Folia Biol, 2008, 56, 73-75.
30. Toohey JI: Persulfide sulfur is a growth factor for cells defective in sulfur metabolism. Biochem Cell Biol, 1986, 64, 758-765.
31. Toohey JI: Sulphane sulphur in biological systems: a possible regulatory role. Biochem J, 1989, 264, 625-632; correction: Biochem J, 1990, 267, 843.
32. Toohey JI: Sulfur signaling: is the agent sulfide or sulfane? Anal Biochem, 2011, 413, 1-7.
33. Vaish V, Sanyal SN: Chemopreventive effects of NSAIDs on cytokines and transcription factors during the early stages of colorectal cancer. Pharmacol Rep, 2011, 63, 210-221.
34. Westley AM, Westley J: Biological sulfane sulfur. Anal Biochem, 1991, 95, 63-67.
35. Westley JAH, Westley L: The sulfurtransferases. Fundam Appl Toxicol, 1983, 3, 377-382.
36. Włodek PJ, Iciek MB, Miłkowski A, Smoleński OB: Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis. Clin Chim Acta, 2001, 304, 9-18.
37. Włodek PJ, Smoleński OB, Chwatko G, Iciek MB, Miłkowski A, Bald E, Włodek L: Disruption of thiol homeostasis in plasma of terminal renal failure patients. Clin Chim Acta, 2006, 366, 137-145.
38. Wood JL: Sulfane sulfur. Methods Enzymol, 1987, 143, 25-29.